Follow Us
© 2026 Arizent. All rights reserved.
(Bloomberg) — Pharmaceutical makers won approval from the California Assembly to restrict generic versions of drugs isolated from natural sources, such as vaccines, known as biosimilars, once they become available in the U.S.
The bill passed Monday would require pharmacies to notify doctors and sometimes patients when a cheaper biosimilar drug is substituted for a brand-name medicine. It also would forbid a pharmacist from substituting the biosimilar drug if the physician says no.
For reprint and licensing requests for this article, click here.
The pharmacy landscape is shifting rapidly—and employers are feeling the pressure.
Rising drug costs are plaguing employers and their workers. These techniques can bring relief.
Ten drugs will be negotiated under Medicare in an element of President Biden's signature Inflation Reduction Act.
The drug stands to become the second shown to clearly slow the disease.
The company believes it could eventually bring glucose monitoring to market, according to people familiar with the effort.
